Search research articles
Contact Us
Filters
Showing results (61-70 of 171) with videos related to
Page
of 18
Sort By:
BJU International
|
December 20, 2005
Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins
R William G Watson, John M Fitzpatrick
BJU International
|
February 13, 2009
Prostate-specific antigen kinetics in localized and advanced prostate cancer
John M Fitzpatrick, Eugeniu Banu, Stephane Oudard
World Journal of Urology
|
March 10, 2011
The role of ethical publishing in promoting the evidence-based practice of urology
Gavin Sharrock, Chris Graf, John M Fitzpatrick
BJU International
|
April 2, 2010
Benign prostatic hyperplasia: counting the cost of its management
Roger S Kirby, Mike Kirby, John M Fitzpatrick
BJU International
|
January 8, 2010
Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer
Roger S Kirby, John M Fitzpatrick, Noel Clarke
European Urology
|
August 23, 2003
Awareness of prostate cancer among the general public: findings of an independent international survey
Claude C Schulman, Roger Kirby, John M Fitzpatrick
BJU International
|
January 22, 2009
Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)
Roger S Kirby, John M Fitzpatrick, Jacques Irani
BJU International
|
January 11, 2008
How the new BJU International website benefits prospective authors
Marcus Drake, Robyn Webber, Frank Gardiner, et al.
BJU International
|
April 18, 2007
What is the role of inflammation in the pathogenesis of prostate cancer?
Miles A Goldstraw, John M Fitzpatrick, Roger S Kirby
Current Urology Reports
|
January 23, 2003
Heat shock proteins in the genitourinary system
R William G Watson, Thierry Lebret, John M Fitzpatrick
Page
of 18
Search research articles
Search
Showing results (61-70 of 171) with videos related to
Sort By:
Page
of 18
BJU International
|
December 20, 2005
Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins
R William G Watson, John M Fitzpatrick
BJU International
|
February 13, 2009
Prostate-specific antigen kinetics in localized and advanced prostate cancer
John M Fitzpatrick, Eugeniu Banu, Stephane Oudard
World Journal of Urology
|
March 10, 2011
The role of ethical publishing in promoting the evidence-based practice of urology
Gavin Sharrock, Chris Graf, John M Fitzpatrick
BJU International
|
April 2, 2010
Benign prostatic hyperplasia: counting the cost of its management
Roger S Kirby, Mike Kirby, John M Fitzpatrick
BJU International
|
January 8, 2010
Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer
Roger S Kirby, John M Fitzpatrick, Noel Clarke
European Urology
|
August 23, 2003
Awareness of prostate cancer among the general public: findings of an independent international survey
Claude C Schulman, Roger Kirby, John M Fitzpatrick
BJU International
|
January 22, 2009
Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)
Roger S Kirby, John M Fitzpatrick, Jacques Irani
BJU International
|
January 11, 2008
How the new BJU International website benefits prospective authors
Marcus Drake, Robyn Webber, Frank Gardiner, et al.
BJU International
|
April 18, 2007
What is the role of inflammation in the pathogenesis of prostate cancer?
Miles A Goldstraw, John M Fitzpatrick, Roger S Kirby
Current Urology Reports
|
January 23, 2003
Heat shock proteins in the genitourinary system
R William G Watson, Thierry Lebret, John M Fitzpatrick
Page
of 18